Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chronic Immune Thrombocytopenia (ITP)

July 19, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search